Primarily focusing on a broad spectrum of joint ventures, M&A, and restructurings, the K&L Gates practice has an ‘in-depth understanding’ of the healthcare, automotive, and financial services industries. Operating out of both Hong Kong and Beijing, Frank Voon leads the team, standing out for his venture capital work, while Shanghai-based Simon Poh routinely acts for international corporations and financial institutions. Max Gu and Yujing Shu are also cited as key contacts.
Legal 500 redaktioneller Kommentar
- Profil
Referenzen
Unabhängig vom Legal 500-Forschungsteam zusammengestellt.
‘The team has an in-depth understanding of the client industry and can provide legal advice that is very accurate, practical and in line with the company's business needs. They are very efficient, and their responses at meetings are fast, ruthless, and accurate. They are a very cost-effective law firm.’
'Frank Voon is a very hands-on partner in the team. He is able to speak Chinese and English.'
'Effectively bilingual, very responsive and has a good technical grasp of the issues at hand.'
- 'They took the time out to explain the legal issues under PRC law to us and also offered workable commercial solutions.'
Kernmandanten
- 17LIVE Holding (17LIVE)
- Dash Living
- Luye Pharma
- Properjob International Limited
- TradeBeyond
Highlight-Mandate
Advised 17LIVE, in its proposed combination with Singapore’s Vertex Technology Acquisition Corporation Ltd (VTAC), a technology-focused special purpose acquisition company (SPAC) backed by Singaporean state investor, Temasek.
Advised Dash Living on its joint venture with PGIM Real Estate for the acquisition and development of The Sheung Wan by Ovolo, a 56-key boutique hotel located in Hong Kong’s central business district and its joint venture with Schroders for the acquisition and development of the Palms Ryogoku, a 49-key multi-family residential asset in Tokyo.
Advised Luye Pharma on its acquisition of the rights to Seroquel in more than 50 international markets, from AstraZeneca, a LSE-listed, FTSE 100 pharmaceutical company.
Anwält*innen
Führende Partner*innen
Die stärksten Partner*innen ihres Praxisbereichs, die eine führende Rolle in signifikanten Mandaten einnehmen und weitreichende Anerkennung unter Wettbewerbern und Mandanten genießen.
Praxisleitung
Frank Voon
Weitere Kernanwält*innen
Simon Poh; Virginia Tam; William Ho; Amigo Xie; Vincent Ts0; Max Gu; Yujing Shu; Henry Wang; Roberta Chang; Chloe Duan; Rong Fan